INGR 81.35 Ingredion Inc $INGR Hit a 52 week high of 81.57

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
INGR 81.35 Ingredion Inc $INGR Hit a 52 week high of 81.57 Closing the day 09:45 at 81.35 +0.01 +0.01% With a day low of 81.16 and a total volume of 43,877.

INGR Recent Posts: http://investorshangout.com/Ingredion-Incorpo...NGR-50606/

INGR Ingredion Inc Recent Headline News

INGREDION EXECUTIVES WILL OUTLINE PATH FORWARD AND LONG-TERM OBJECTIVES AT ANALYST DAY TODAY; FOCUS ON HIGH-VALUE SPECIALTY INGREDIENTS
Thomson Reuters ONE - Tue Nov 18, 7:02AM CST
BRIDGEWATER, N.J., November 18, 2014 - Today senior executives of Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to diversified industries, will present a business overview to investment analysts. Future growth drivers, financial performance and long-term objectives driving the Company's success will be reviewed. As previously announced, the Analyst Day presentation will be webcast.
INGR: 81.04 (-0.30)

Equity Selections For Your Retirement Portfolios: 39 Dividend Growth Stocks For Total Return: Part 1
Chuck Carnevale - at Seeking Alpha - Tue Nov 18, 6:30AM CST

USTR: 41.57 (-0.64), EPS: 71.49 (-0.32), EMN: 84.99 (-0.50), INGR: 81.04 (-0.30), TEL: 61.47 (-0.25), HAL: 47.96 (-0.58), M: 61.98 (+0.53), AET: 86.04 (-1.12)

Dividend Challengers (And Near-Challengers): 44 Increase Expected By January 31
David Fish - at Seeking Alpha - Mon Nov 17, 3:57AM CST

WDFC: 74.64 (-1.16), EWBC: 36.28 (-0.31), TTC: 62.71 (+0.05), OCR: 70.48 (-0.25), GE: 26.81 (-0.20), MAIN: 32.32 (+0.04), HI: 33.00 (-0.83), DEI: 27.30 (-0.17), BLX: 31.65 (-0.49), THG: 69.49 (-0.28), RL: 177.35 (+0.79), BCPC: 63.13 (-1.59), AET: 86.04 (-1.12), VTR: 68.72 (-0.31), WDR: 48.20 (-0.36), TLLP: 56.68 (-0.52), PCBK: 13.75 (-0.29), EME: 44.03 (-0.66), EPR: 55.67 (-0.48), CHS: 15.23 (+0.15), LGCY: 19.19 (-0.46), BMR: 21.09 (-0.27), EMN: 84.99 (-0.50), INGR: 81.04 (-0.30), PRA: 45.01 (-0.14), CUBE: 20.92 (-0.21), DIS: 89.28 (-1.00), COR: 37.46 (-0.47), BMY: 58.63 (-0.07), MORN: 67.42 (-0.72), EXL: 12.67 (-0.05), RAS: 7.06 (-0.07), CLB: 134.88 (-2.01), RCII: 31.74 (+0.07), TESS: 28.24 (-1.04), BGS: 28.60 (-0.30), TOO: 25.77 (-1.14), FIBK: 27.82 (-0.64), MAA: 71.90 (-0.57), HEI: 51.05 (-0.53), JCI: 50.29 (+0.06)

INGREDION TO WEBCAST PRESENTATION TO ANALYSTS ON NOVEMBER 18, 2014
Thomson Reuters ONE - Thu Nov 06, 12:29PM CST
WESTCHESTER, Ill., Nov. 6, 2014 - Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to diversified industries, will webcast its Analyst Day presentation on Tuesday, November 18, 2014. Ingredion's senior executives will present a business overview, including a review of future growth drivers, financial performance and long-term targets for the Company.
INGR: 81.04 (-0.30)

5 Takeaways From Ingredion's Quarterly Statement
William Bias - at Seeking Alpha - Thu Nov 06, 8:07AM CST

INGR: 81.04 (-0.30)

Ingredion: A Safe Haven With Improving Prospects
Darspal S Mann - at Seeking Alpha - Wed Nov 05, 9:11AM CST

INGR: 81.04 (-0.30)

INVESTOR ALERT: The Law Offices of Vincent Wong Investigates the Board of Directors of Penford Corporation Regarding the Fairness of the Sale of the Company to Ingredion Incorporated - PENX
PR Newswire - Tue Nov 04, 11:04AM CST
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Penford Corporation (NasdaqGM: PENX) ("Penford" in connection with the sale of the Company to Ingredion Incorporated (NYSE: INGR).
INGR: 81.04 (-0.30), PENX: 18.84 (+0.02)

Ingredion Incorporated's (INGR) CEO Ilene Gordon on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 5:40PM CDT

INGR: 81.04 (-0.30)

Ingredion meets 3Q profit forecasts
Automated Insights - Thu Oct 30, 10:24AM CDT
WESTCHESTER, Ill. (AP) _ Ingredion Inc. (INGR) on Thursday reported third-quarter net income of $118.6 million.
INGR: 81.04 (-0.30)

Ingredion beats by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 8:20AM CDT

INGR: 81.04 (-0.30)

INGREDION INCORPORATED REPORTS SOLID THIRD QUARTER 2014 RESULTS
Thomson Reuters ONE - Thu Oct 30, 5:30AM CDT
- Third quarter 2014 EPS rose 45 percent to $1.60 from $1.10 in the third quarter 2013
INGR: 81.04 (-0.30)

Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 4:30PM CDT

FIS: 59.57 (-0.23), HST: 22.42 (-0.34), CRR: 45.95 (-0.94), CAH: 80.00 (-1.01), AMT: 100.65 (unch), ACIW: 19.49 (-0.23), GTI: 4.20 (-0.08), IDA: 61.65 (-0.50), CRCM: 8.55 (-0.10), CVRR: 23.76 (-0.10), BGCP: 8.77 (-0.04), GOV: 22.88 (-0.13), DFT: 30.44 (-0.24), APO: 22.97 (-0.37), FIG: 7.65 (-0.20), AMAG: 35.49 (+0.15), HAR: 107.62 (-1.66), AVP: 9.49 (-0.41), EXLS: 27.39 (-0.39), INGR: 81.04 (-0.30), ALU: 3.17 (-0.05), INCY: 71.60 (+1.96), COP: 71.77 (+0.10), GEL: 47.84 (-0.36), COR: 37.46 (-0.47), GTLS: 42.30 (-0.81), BWA: 56.85 (-0.39), CARB: 11.29 (-0.14), GLOP: 22.32 (-0.75), IDCC: 49.10 (-0.98), HEES: 35.59 (-0.67), BCO: 21.00 (-0.52), DST: 98.55 (-0.88), EPD: 38.14 (+0.54), ABMD: 34.76 (-0.12), CEVA: 15.66 (-0.53), BLL: 64.52 (-0.41), GBX: 63.82 (-0.63), GNC: 43.05 (+0.16), CVI: 47.26 (+0.11), ACOR: 34.81 (+0.28), I: 17.05 (-0.36), FCN: 39.48 (-1.25), CRNT: 1.05 (-0.02), DHX: 11.01 (-0.27), BG: 89.51 (-0.53), CME: 83.03 (-0.68), FCH: 10.25 (-0.16), ALLE: 53.71 (-0.16), AUDC: 4.70 (+0.01), APD: 141.75 (+2.85), DBD: 34.70 (-0.26), HGG: 6.01 (-0.03), CBM: 22.44 (-0.29), CNSL: 26.76 (-0.43), ATK: 113.40 (-0.76), ANR: 2.26 (-0.17), CI: 102.81 (-1.14), ABC: 89.10 (-0.66), GG: 20.42 (-0.87)

PENFORD CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
Business Wire - Tue Oct 28, 10:55AM CDT
Rigrodsky & Long, P.A.:
INGR: 81.04 (-0.30), PENX: 18.84 (+0.02)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Penford Corporation of Class Action Against the Board of Directors of the Company Regarding the Fairness of the Sale of the Company to Ingredion Incorporated -- PENX
GlobeNewswire - Tue Oct 28, 10:29AM CDT
Levi & Korsinsky notifies investors of Penford Corporation ("Penford" or "the Company" (Nasdaq ENX) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to Ingredion Incorporated (NYSE:INGR). A complaint was filed in Colorado federal court.
INGR: 81.04 (-0.30), PENX: 18.84 (+0.02)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Penford Corporation Regarding the Fairness of the Sale of the Company to Ingredion Incorporated -- PENX
Business Wire - Mon Oct 27, 10:01AM CDT
Levi & Korsinsky is investigating the Board of Directors of Penford Corporation ("Penford" or "the Company" (NasdaqGM: PENX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Ingredion Incorporated (NYSE: INGR).
INGR: 81.04 (-0.30), PENX: 18.84 (+0.02)

INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Penford Corporation Concerning the Fairness of the Sale of the Company to Ingredion Incorporated -- PENX
PR Newswire - Mon Oct 20, 10:05AM CDT
Levi & Korsinsky is investigating the Board of Directors of Penford Corporation ("Penford" or "the Company" (NasdaqGM: PENX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Ingredion Incorporated (NYSE: INGR).
INGR: 81.04 (-0.30), PENX: 18.84 (+0.02)

Assessing Risk In Equities In The Consumer Staple Sector
Factoids - at Seeking Alpha - Mon Oct 20, 3:04AM CDT

KO: 44.10 (+0.57), MKC: 72.55 (+0.05), CLX: 100.62 (-0.15), CAG: 35.65 (unch), HSY: 95.51 (-1.00), INGR: 81.04 (-0.30), KMB: 113.57 (-0.03), HRL: 55.19 (+0.08), SJM: 101.68 (-0.29), PEP: 98.22 (+0.28), K: 65.86 (+0.26), ADM: 52.11 (+0.10), CPB: 44.54 (-0.02), LANC: 92.07 (-0.35), PG: 88.58 (+0.63), FLO: 19.34 (-0.11), GIS: 51.65 (+0.06), CL: 67.98 (+0.01)

Dividend Challengers (And Near-Challengers): 57 Increases Expected By New Year's Day
David Fish - at Seeking Alpha - Sat Oct 18, 5:51PM CDT

RKT: 55.81 (-0.15), TTC: 62.71 (+0.05), HST: 22.42 (-0.34), OCR: 70.48 (-0.25), HI: 33.00 (-0.83), MAIN: 32.32 (+0.04), MHLD: 12.72 (-0.04), PRU: 83.74 (-0.26), DEI: 27.30 (-0.17), PSA: 185.61 (-0.85), THG: 69.49 (-0.28), KKR: 22.82 (+0.13), RL: 177.34 (+0.78), VTR: 68.72 (-0.31), AEP: 57.12 (-0.13), EVR: 49.75 (-1.20), TECH: 89.60 (-0.76), ROK: 109.99 (-0.90), INGR: 81.04 (-0.30), WTI: 9.46 (-0.19), COR: 37.46 (-0.47), EXL: 12.67 (-0.05), UG: 20.45 (-0.10), BGS: 28.60 (-0.30), ESV: 38.54 (-0.64), APTS: 8.62 (-0.08), EL: 72.09 (+0.06), HEI: 51.05 (-0.53), GE: 26.82 (-0.19), BOKF: 66.20 (-0.80), SNA: 135.47 (-0.55), BCPC: 63.13 (-1.59), SBUX: 77.89 (+0.32), V: 248.63 (-1.10), KIM: 24.83 (-0.02), BBSI: 22.72 (-0.36), SIX: 40.20 (-0.60), EMCI: 29.94 (-0.67), CHS: 15.23 (+0.15), NEU: 385.91 (-1.97), BMR: 21.09 (-0.27), EMN: 85.00 (-0.49), PRA: 45.01 (-0.14), CBL: 18.88 (+0.06), CUBE: 20.92 (-0.21), DIS: 89.28 (-1.00), BMY: 58.63 (-0.07), ABC: 89.12 (-0.64), RCII: 31.74 (+0.07), WCN: 48.84 (-0.42), HCI: 39.81 (-1.06), MAC: 75.15 (+5.27), AMTD: 34.49 (-0.16), HUB.B: 109.11 (-0.64), JCI: 50.30 (+0.07)

PENFORD CORPORATION INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penford Corporation
PR Newswire - Wed Oct 15, 5:28PM CDT
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF" are investigating the proposed sale of Penford Corporation ("Penford" or the "Company" (NASDAQ: PENX) to Ingredion Incorporated (NYSE: INGR). Under the terms of the proposed transaction, shareholders of Penford will receive only $19 in cash for each share of Penford common stock that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
INGR: 81.04 (-0.30), PENX: 18.84 (+0.02)

Ingredion Incorporated (INGR) Stock Research Links

INGR Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Insilico Joins HKEX Tech 100: AI and Pharma Synergies

Updated Category News Views 0

Insilico Medicine just locked down a spot in the HKEX Tech 100 Index, and that's a pretty big deal, if you ask me. This Cambridge-based outfit is making waves with its generative AI wizardry in drug discovery. It's not just about earning a tech badge of honor here; it's about opening doors to new investors and bolstering liquidity. When changes hit on September 14, 2026,...

Continue Reading
Aurzen's ZIP Pro: A Mobile Cinema Revolution?

Updated Category News Views 3

Aurzen ZIP Pro: A Big Splash in Times Square In the bustling heart of Manhattan, the glitz and glam of Times Square will shine a bit brighter this Fall. Why? Because Aurzen's introducing their latest gadget, the ZIP Pro. It’s a tri-fold Full HD pocket projector that, frankly, is aiming to redefine portable viewing. Boasting the ability to unfurl an 80-inch...

Continue Reading
Ace Hardware Hits 100th Store Milestone, Talks Growth

Updated Category News Views 3

Ace Hardware Signals Expansion Through 100th Store Anyone eying the hardware retail landscape knows that Ace Hardware is not just coasting through another predictable quarter. No, this coop, fondly dubbed the helpful hardware folks, has just cranked open the doors on its 100th new store of 2026. Yep, they're charging full-throttle on their expansion strategy, determined...

Continue Reading
Fibocom's RU311: Navigating 5G's Mid-Tier Maze

Updated Category News Views 4

Cracking Open the RU311 Phenomenon Technology must evolve with purpose. This time around, Fibocom's RU311 module series steps up to the plate, delivering a tailored solution in the 5G landscape for the mid-tier IoT devices that need more than just speed. Beyond Raw Bandwidth: What Really Matters Plenty of folks out there still chase the elusive thrill of higher speeds as...

Continue Reading
Texas Institute Leads Trailblazing Arrhythmia Study

Updated Category News Views 2

Breaking New Ground in Heart Rhythm Treatment Well, here's a twist that even the stock market folks might envy—pioneering innovation in healthcare. This time, it’s not about tech stocks or a bull market, but about real human lives. The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center in Austin has jumped to the forefront by participating in a...

Continue Reading
BOC Group's Challenger Role Eye-Opener in Gartner Quadrant

Updated Category News Views 6

Cracking the Challenger Code: BOC Group's Debut Ever heard of BOC Group? If you haven’t, it’s time to pay attention. This Dublin-based outfit just muscled its way into the Challenger Quadrant of the 2026 Gartner Magic Quadrant for Digital Twin of an Organization Platforms. Not bad for its first trip to the dance. When a company crashes the scene like this, eyebrows...

Continue Reading
K-Royal Culture Festival 2026: A Global Heritage Experience

Updated Category News Views 1

The K-Royal Culture Festival is rolling out in Fall 2026 with a flair that promises to capture the globetrotters' imaginations and then some. South Korea's signature national heritage jamboree is popping off from October 7 through October 11, 2026, at four magnificent palaces and the Jongmyo Shrine. If you're into discovering the depths of a place's history through...

Continue Reading
Veteran Suicide Prevention: The Urgency Behind CVN's Push

Updated Category News Views 1

Veteran suicide is a crisis staring us square in the face, with rates 60% higher than the general population. It's a grim reminder that the mental toll on those who've served is a deep chasm hard to bridge. Cohen Veterans Network (CVN) is stepping up to the plate with a new campaign dubbed 'Ask Anyway: Conversations to Save a Life'. This isn't just any awareness...

Continue Reading
Viventium's New Healthcare Platform: A Game Changer

Updated Category News Views 2

Revolution in Workforce Management for Healthcare When a healthcare company like Viventium decides to expand its human capital management (HCM) platform, you've got to sit up and take notice, especially in a field that's been biting its nails over workforce headaches for years. Staffing shortages, growing compliance hurdles, and labor costs squeezing tighter than...

Continue Reading
Tahoe Truckee Life TV Series Elevates Local Flavor

Updated Category News Views 1

Meet “Tahoe Truckee Life” Kane Schaller, the face of the Tahoe Truckee Life series, is giving folks a front-row seat to the lives and landscapes that make the Reno-Tahoe region buzz. Now, I've seen shows trying to pull this off, but this one might just spark something genuine if done right. The Real Deal on Reno-Tahoe The show airs on the REAL Shows Network—a...

Continue Reading

Top 5 Most Recently Viewed Articles

BingX Launches Crypto Friday Series for Trading Empowerment

Updated Category News Views 136

BingX Unveils Engaging Crypto Friday Video Series BingX, a leading cryptocurrency exchange and Web3 AI company, has recently introduced an innovative video initiative known as BingX Crypto Friday. This series aims to empower traders by offering them crucial insights and guidelines to enhance their trading experiences. The first episode is available on various social...

Continue Reading
IZEA Welcomes Kerry Griffin as Pioneering Chief Talent Officer

Updated Category News Views 248

IZEA Welcomes Kerry Griffin as Chief Talent Officer IZEA Worldwide, Inc. (NASDAQ: IZEA), recognized for its services and technologies in the Creator Economy, has made a significant announcement with the appointment of Kerry Griffin as its inaugural Chief Talent Officer (CTO). This strategic decision emphasizes IZEA’s commitment to nurturing a skilled workforce and...

Continue Reading
Neumora Therapeutics Faces Legal Action: Key Insights for Investors

Updated Category News Views 85

Neumora Therapeutics Faces a Securities Class Action Lawsuit In an important development for investors, a securities class action lawsuit has been initiated in a federal court concerning the operations of Neumora Therapeutics, Inc. As a clinical-stage biopharmaceutical company, Neumora is known for developing promising therapeutic treatments aimed at addressing complex...

Continue Reading
The Transformation of Corporate Finance Using AI Innovations

Updated Category News Views 218

A New Era in Corporate Finance Driven by AI Corporate finance is currently experiencing a remarkable transformation, thanks to the advent of artificial intelligence and autonomous technologies. These innovations are redefining the role of Chief Financial Officers (CFOs) and enhancing the efficiency of finance teams across various organizations. Recent insights from...

Continue Reading
Historic All-Female Spaceflight Marks New Beginning for Exploration

Updated Category News Views 270

Breaking New Ground in Space Exploration The remarkable journey of Blue Origin's NS-31 mission represents a significant milestone in the realm of space exploration and connects various pioneering stories of individuals reaching for the stars. This noteworthy mission made headlines as it features the first-ever all-female crew, showcasing the capabilities and aspirations...

Continue Reading